Viper has completed over $4 billion in deals outside of the cardiology space, and now has several surgical cardiology and subspecialty groups under contract.
Viper plans to enter the industry due to a low concentration of private equity in cardiology, an aging population and new changes to Medicare and Medicaid rules.
“We have been watching this area for a couple years and feel the time is perfect to bring our experience to this exciting space,” Samir Qureshi, Viper’s vice president, said in a Jan. 19 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.